(BOLT) Bolt Biotherapeutics - Performance -73.1% in 12m
Compare BOLT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-88.36%
#164 in Group
Rel. Strength
6.03%
#7477 in Universe
Total Return 12m
-73.08%
#139 in Group
Total Return 5y
-98.89%
#181 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: BOLT (-73.1%) vs XBI (-14.9%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: BOLT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BOLT
| Total Return (including Dividends) | BOLT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 10.60% | 2.77% | 5.69% |
| 3 Months | -23.01% | -14.21% | -6.49% |
| 12 Months | -73.08% | -14.88% | 9.72% |
| 5 Years | -98.89% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | BOLT | XBI | S&P 500 |
| 1 Month | 34.3% | 57% | 89.4% |
| 3 Months | -87.8% | -82.3% | -72% |
| 12 Months | -97.7% | -53.1% | 49.3% |
| 5 Years | -97.5% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #174 | 7.61% | 4.64% |
| 3 Month | #144 | -10.3% | -17.7% |
| 12 Month | #139 | -68.4% | -75.5% |
| 5 Years | #172 | -97.6% | -99.3% |
FAQs
Does BOLT Bolt Biotherapeutics outperforms the market?
No,
over the last 12 months BOLT made -73.08%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months BOLT made -23.01%, while XBI made -14.21%.
Over the last 3 months BOLT made -23.01%, while XBI made -14.21%.
Performance Comparison BOLT vs Indeces and Sectors
BOLT vs. Indices BOLT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.29% | 4.91% | -38.6% | -82.8% |
| US NASDAQ 100 | QQQ | 3.02% | 3.21% | -39.0% | -83.9% |
| US Dow Jones Industrial 30 | DIA | 3.40% | 7.93% | -37.5% | -79.3% |
| German DAX 40 | DAX | 2.84% | -4.46% | -64.1% | -97.9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.06% | 7.72% | -37.8% | -79.4% |
| Hongkong Hang Seng | HSI | 0.41% | -4.30% | -48.1% | -81.3% |
| India NIFTY 50 | INDA | 6.99% | 7.39% | -40.5% | -75.1% |
| Brasil Bovespa | EWZ | 0.26% | -1.02% | -47.8% | -66.8% |
BOLT vs. Sectors BOLT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.92% | 4.12% | -44.7% | -93.5% |
| Consumer Discretionary | XLY | 1.87% | 3.91% | -36.4% | -87.9% |
| Consumer Staples | XLP | 4.15% | 9.90% | -45.5% | -80.3% |
| Energy | XLE | 1.04% | 6.11% | -32.6% | -64.1% |
| Financial | XLF | 2.59% | 3.76% | -44.4% | -94.6% |
| Health Care | XLV | 7.39% | 13.7% | -33.3% | -67.1% |
| Industrial | XLI | 2.36% | 2.29% | -39.5% | -83.5% |
| Materials | XLB | 3.13% | 5.56% | -34.5% | -67.0% |
| Real Estate | XLRE | 4.08% | 3.69% | -40.9% | -86.7% |
| Technology | XLK | 2.45% | 0.89% | -36.3% | -79.2% |
| Utilities | XLU | 2.57% | 5.46% | -46.3% | -89.1% |
| Aerospace & Defense | XAR | 3.11% | 1.43% | -47.9% | -99.0% |
| Biotech | XBI | 11.0% | 7.83% | -17.5% | -58.2% |
| Homebuilder | XHB | 3.65% | 4.99% | -24.9% | -64.2% |
| Retail | XRT | 3.23% | 4.46% | -32.3% | -66.8% |